Dbv Technologies Sa · EURONEXT:DBV
Venrock Healthcare Capital Partners II, L.P. reported a 9.80% stake in Dbv Technologies Sa (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Venrock Healthcare Capital Partners II, L.P. reported a 9.80% stake in Dbv Technologies Sa, 14,286,553 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 9.80%
- Shares
- 14,286,553
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Venrock Healthcare Capital Partners II, L.P. | 9.80% | 14,286,553 |
| VHCP Co-Investment Holdings II, LLC | 9.80% | 14,286,553 |
| VHCP Management II, LLC | 9.80% | 14,286,553 |
| Venrock Healthcare Capital Partners III, L.P. | 9.80% | 14,286,553 |
| VHCP Co-Investment Holdings III, LLC | 9.80% | 14,286,553 |
| Venrock Healthcare Capital Partners EG, L.P. | 9.80% | 14,286,553 |
| VHCP Management III, LLC | 9.80% | 14,286,553 |
| VHCP Management EG, LLC | 9.80% | 14,286,553 |
| Nimish Shah | 9.80% | 14,286,553 |
| Bong Y. Koh | 9.80% | 14,286,553 |
Source
Related
- Dbv Technologies Sa
- Venrock Healthcare Capital Partners II, L.P.
- Dbv Technologies Sa shareholders
- Schedule 13G/A · Venrock Healthcare Capital Partners II, L.P. · Feb 17, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners II, L.P. · Nov 14, 2025
- AMF threshold crossing notice · J.P. Morgan Chase & Co. · Oct 22, 2026
- AMF threshold crossing notice · J.P. Morgan Chase & Co. · Oct 19, 2026
- AMF threshold crossing notice · J.P. Morgan Chase & Co. · Oct 13, 2026
- Schedule 13G/A · Mpm Bioimpact LLC · Aug 14, 2026
- Schedule 13G · Ra Capital Management, L.P. · Aug 6, 2026